We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

202 hedge funds and large institutions have $1.03B invested in PDL BioPharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 202 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $1.09M

Holders
202
Holders Change
+202
Holders Change %
–
% of All Funds
6.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
202
Increased
–
Reduced
–
Closed
–
Calls
$2.13M
Puts
$1.09M
Net Calls
+$1.04M
Net Calls Change
+$1.04M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TYCC
126
Texas Yale Capital Corp
Florida
$295K +$297K +38,150 New
RJA
127
Raymond James & Associates
Florida
$294K +$297K +38,065 New
FSA
128
Franklin Street Advisors
North Carolina
$289K +$292K +37,500 New
VFS
129
VSR Financial Services
Kansas
$284K +$287K +36,830 New
U
130
UBS
Switzerland
$247K +$249K +31,969 New
GF
131
Gerstein Fisher
New York
$241K +$243K +31,222 New
IRS
132
Invictus RG (Singapore)
Singapore
$216K +$219K +28,022 New
SBCM
133
Silver Bridge Capital Management
Massachusetts
$207K +$210K +26,868 New
DC
134
Deere & Company
Illinois
$200K +$202K +25,891 New
Legal & General Group
135
Legal & General Group
United Kingdom
$196K +$198K +25,381 New
AL
136
Airain Ltd
Guernsey
$189K +$191K +24,494 New
PP
137
Paloma Partners
Connecticut
$187K +$189K +24,196 New
VRS
138
Virginia Retirement Systems
Virginia
$187K +$189K +24,200 New
ACM
139
Ativo Capital Management
Illinois
$183K +$184K +23,642 New
BA
140
Boston Advisors
Massachusetts
$183K +$185K +23,730 New
B
141
BancorpSouth
Mississippi
$168K +$170K +21,800 New
T
142
TradeWorx
New Jersey
$156K +$157K +20,148 New
Nisa Investment Advisors
143
Nisa Investment Advisors
Missouri
$154K +$156K +20,000 New
CAN
144
Cetera Advisor Networks
California
$143K +$143K +18,390 New
DCM
145
Dynamic Capital Management
Jersey
$137K +$138K +17,739 New
OC
146
Oppenheimer & Co
New York
$135K +$136K +17,400 New
PP
147
PDT Partners
New York
$135K +$136K +17,500 New
CIP
148
Convergence Investment Partners
Florida
$132K +$133K +17,050 New
OTPPB
149
Ontario Teachers' Pension Plan Board
Ontario, Canada
$131K +$132K +16,946 New
CIM
150
Contravisory Investment Management
Massachusetts
$129K +$131K +16,750 New
4 5
6
7 8

PDLI Hedge Fund Activity: Q2 2013 in Review

202 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q2 2013, worth a combined $1.03B.

Buyers outnumbered sellers: 202 funds opened new PDLI positions and 0 closed out — a net gain of 202 holders — while 0 added to existing stakes and 0 trimmed.

  • 202 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.03B of PDL BioPharma, Inc. stock for Q2 2013.
  • 202 funds opened new PDL BioPharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +202 holders.

Based on aggregated 13F filings for Q2 2013.